Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
21 hedge funds and large institutions have $9.55M invested in Psychemedics Corporation in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
13% less capital invested
Capital invested by funds: $11M → $9.55M (-$1.42M)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
16% less funds holding
Funds holding: 25 → 21 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$90.6K |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
+$69.9K |
| 3 |
WE
Wealth Effects
Boston,
Massachusetts
|
+$34K |
| 4 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
+$5.17K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$590K |
| 2 |
Renaissance Technologies
New York
|
-$97.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$83K |
| 4 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
-$14K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$9.03K |
PMD Hedge Fund Activity: Q2 2022 in Review
21 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2022, worth a combined $9.55M — down 13% from $11M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PMD and 0 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Morgan Stanley, adding an estimated $90.6K. The largest seller was Invenomic Capital Management, cutting an estimated $590K.
- 21 institutional investors held Psychemedics Corporation (PMD) as of Q2 2022, down from 25 in Q1 2022.
- Funds reported $9.55M of Psychemedics Corporation stock for Q2 2022, down 13% quarter-over-quarter.
- 0 funds opened new Psychemedics Corporation positions in Q2 2022 and 3 closed out, a net change of -3 holders.
- The largest Psychemedics Corporation buyer in Q2 2022 was Morgan Stanley, an estimated $90.6K added.
- The largest Psychemedics Corporation seller in Q2 2022 was Invenomic Capital Management, an estimated $590K sold.
Based on aggregated 13F filings for Q2 2022.